Eli Lilly: Will A New Rival Hobble Its Top Growth Driver? By: Stocks to Watch August 17, 2017 at 12:17 PM EDT A rival diabetes drug bested Eli Lilly's top growth driver in a recent clinical trial. What does this mean for the U.S. pharmaceutical giant. Read More >>